Johnson & Johnson - Search News

News

Johnson & Johnson, Q2 Estimates

Johnson & Johnson Beats Earnings Estimates. Financial Chief Says It Can Do Any Deal It Wants.

The drug and medical device maker Johnson & Johnson kicked off the healthcare earnings season with a better-than-anticipated report early Wednesday, as sales and earnings came in above expectations.That’s a good sign for the healthcare sector,

Reuters on MSN · 9h

Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales

Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on strong demand for its cancer drug, Darzalex, and strength in its medical device business.

Investopedia on MSN · 8h

Johnson & Johnson Tops Q2 Estimates, Lifts Outlook for Sales and Profit

Johnson & Johnson (JNJ) on Wednesday lifted its full-year projections and reported second quarter results that beat estimates. The medical device and drug maker posted adjusted earnings per share of $2.

Johnson, stock and Profit

MarketWatch on MSN · 3h

Johnson & Johnson’s stock surges as tariff cost estimate slashed and profit outlook raised

Adjusted earnings per share for the quarter to June 29 fell to $2.77 from $2.82 in the same period a year ago, and topped the average analyst EPS estimate compiled by FactSet of $2.68.

Investopedia on MSN · 8h

Johnson & Johnson Stock Jumps on Strong Earnings, Higher Outlook

Johnson & Johnson (JNJ) shares surged Wednesday after the company reported second-quarter results that topped estimates and the company lifted its full-year outlook. The shares were up over 6% in recent trading,

The Wall Street Journal on MSN · 2h

J&J Raises Full-Year Outlook After Beating Profit Expectations

Johnson & Johnson boosted its full-year outlook as it posted better-than-expected profit and sales in the second quarter.

Mike Johnson calls for 'transparency' in Epstein case

NBC News on MSN · 8h

Mike Johnson calls for Epstein files and ICE memos gives deportation guidance: Morning Rundown

Donald Trump brushes off his supporters’ interest in the Jeffrey Epstein case, and House Speaker Mike Johnson speaks out.

USA TODAY on MSN · 20h

Mike Johnson calls for 'transparency' in Epstein case, in a break with Trump

The House Speaker said he is "for transparency," in a moves that breaks with Trump's calls to move on from the Epstein case review.

CBS News · 6h

Speaker Mike Johnson calls for transparency over Epstein documents

Speaker of the House Mike Johnson, an ally of President Trump, is another Republican who is now calling for greater transparency and the release of the Jeffrey Epstein documents. Johnson also said there needs to be more of an explanation from Attorney General Pam Bondi regarding her comments on the files as the issue divides the GOP.

Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

Johnson & Johnson shrugs off tariff impact and forecasts sales boost

In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its ...

C.J. Gardner-Johnson Apologizes to Eagles for 'Won't See a Ring' Comments After Trade

C.J. Gardner-Johnson said he "retracts" the comments he made about the Philadelphia Eagles after he was traded to the Houston ...

4hon MSN

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

The Motley Fool. DATE Wednesday, July 16, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

Life-Extension Guru Bryan Johnson Says He Has Way More Microplastics in His Semen Than His Blood

Johnson shared yet another personal insight that nobody asked for: His jizz has substantially more microplastics in it than ...

6hon MSN

Democratic state Sen. Nathan Johnson announces run for Texas attorney general

The third-term Democrat from Dallas faces long odds in a state that has only elected Republicans to statewide office for ...

1don MSN

Johnson & Johnson Q2 Preview: Focus on tariff threat, MedTech softness

Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.

10hon MSN

Inside Lane Johnson’s OL Masterminds, which brings top NFL linemen and the next generation together

OL Masterminds, the brainchild of Johnson and O-line guru Duke Manyweather, is an annual summit for linemen who want to share ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Johnson & Johnson, Q2 Estimates

Johnson, stock and Profit

Mike Johnson calls for 'transparency' in Epstein case

Related topics